Stock Rich List
#1615 on the rich list of 14,644 insiders

Lawrence Klein

Chief Executive Officer at Oruka Therapeutics; CBO & COO at CRISPR Therapeutics AG; Director at Jade Biosciences. Based in Menlo Park, California.

$91.2M
in disclosed stock, +$1.7M (+1.85%) today
Market closed. Prices as of Nov 19, 4:00 PM ET
Rank
1615th of 14,644
Companies held
4
Largest holding
ORKA, 98.8% of total
Latest SEC filing
Nov 2, 2026

What the $91.2M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Oruka Therapeutics ORKA
Common Stock
Directly923,128$97.57$90.1M98.8%Form 4, Nov 2, 2026
CRISPR Therapeutics AG CRSP
Common Shares
Directly26,797$38.93$1.0M1.1%Form 4, Mar 14, 2022
Jade Biosciences JBIO
Common Stock
Directly2,463
split-adjusted
$15.06$37K0.0%Form 3, Apr 28, 2025
Jasper Therapeutics JSPR
Voting Common Stock
Directly82
split-adjusted
$10.75$8780.0%Form 4, Oct 12, 2022

Share counts are the amounts Lawrence Klein reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 2, 2026SoldORKA6,466$94.77$613KView
Nov 2, 2026SoldORKA15,036$95.64$1.4MView
Nov 2, 2026SoldORKA2,442$96.70$236KView
Nov 2, 2026SoldORKA756$97.45$74KView
Nov 2, 2026SoldORKA300$98.40$30KView
Oct 1, 2026SoldORKA16,246$83.40$1.4MView
Oct 1, 2026SoldORKA8,554$84.03$719KView
Oct 1, 2026SoldORKA200$84.78$17KView
Sep 15, 2026SoldORKA2,452$95.71$235KView
Sep 1, 2026SoldORKA4,800$92.44$444KView
Sep 1, 2026SoldORKA63,596$91.90$5.8MView
Sep 1, 2026SoldORKA6,604$90.79$600KView
Jun 15, 2026SoldORKA1,729$69.69$120KView
Mar 16, 2026SoldORKA1,729$41.30$71KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1612Victoria Valenzuela
Director, AppLovin. Palo Alto, CA
$91.4M−$2.9M (−3.04%)
1613Gilbert L. Baird III
Director, The RealReal. New York, NY
$91.2M−$6.1M (−6.26%)
1614Yahui Zhou
Director, Opay
$91.2M−$2.7M (−2.87%)
1615Lawrence Klein
Chief Executive Officer, Oruka Therapeutics. Menlo Park, CA
$91.2M+$1.7M (+1.85%)
1616Junli Yang
DIRECTOR & CHAIRWOMAN, TOP Financial Group
$91.1M−$376K (−0.41%)
1617Laurence Zuriff
Director, Xometry. North Bethesda, MD
$91.1M−$7.4M (−7.54%)
1618Angela K. Janssen
Insider, Heartland Express. North Liberty, IA
$91.1M−$1.2M (−1.27%)

Other Oruka Therapeutics insiders

All ORKA insiders

Questions

How much stock does Lawrence Klein own?

Lawrence Klein holds $91,150,781 in listed stock based on SEC filings and current prices, mostly Oruka Therapeutics (ORKA). That ranks 1615th on the Stock Rich List.

Is this Lawrence Klein's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Lawrence Klein last buy or sell stock?

The most recent open-market trade on file is a sale of 6,466 ORKA shares on Nov 2, 2026 at $94.77.